Correlation Between AptarGroup and Central Proteina

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AptarGroup and Central Proteina at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptarGroup and Central Proteina into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AptarGroup and Central Proteina Prima, you can compare the effects of market volatilities on AptarGroup and Central Proteina and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptarGroup with a short position of Central Proteina. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptarGroup and Central Proteina.

Diversification Opportunities for AptarGroup and Central Proteina

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between AptarGroup and Central is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding AptarGroup and Central Proteina Prima in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Central Proteina Prima and AptarGroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptarGroup are associated (or correlated) with Central Proteina. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Central Proteina Prima has no effect on the direction of AptarGroup i.e., AptarGroup and Central Proteina go up and down completely randomly.

Pair Corralation between AptarGroup and Central Proteina

Considering the 90-day investment horizon AptarGroup is expected to generate 0.56 times more return on investment than Central Proteina. However, AptarGroup is 1.78 times less risky than Central Proteina. It trades about 0.1 of its potential returns per unit of risk. Central Proteina Prima is currently generating about 0.03 per unit of risk. If you would invest  13,078  in AptarGroup on January 20, 2024 and sell it today you would earn a total of  833.00  from holding AptarGroup or generate 6.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy85.48%
ValuesDaily Returns

AptarGroup  vs.  Central Proteina Prima

 Performance 
       Timeline  
AptarGroup 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in AptarGroup are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, AptarGroup may actually be approaching a critical reversion point that can send shares even higher in May 2024.
Central Proteina Prima 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Central Proteina Prima has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Central Proteina is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

AptarGroup and Central Proteina Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AptarGroup and Central Proteina

The main advantage of trading using opposite AptarGroup and Central Proteina positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptarGroup position performs unexpectedly, Central Proteina can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Central Proteina will offset losses from the drop in Central Proteina's long position.
The idea behind AptarGroup and Central Proteina Prima pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities